title: Inflammation in peritoneal dialysis: a Latin-American perspective.
abstract: Peritoneal dialysis (PD) patients present an extremely high mortality rate, but the mechanisms mediating the increased risk of mortality observed in this group of patients are still largely unknown, which limits the perspective of effective therapeutic strategies. The leading hypothesis that tries to explain this high mortality risk is that PD patients are exposed to a number of traditional risk factors for cardiovascular disease (CVD) already at the onset of their chronic kidney disease (CKD), since many of these risk factors are common to both CVD and CKD. Of particular importance, chronic inflammation recently emerged as an important novel risk factor related to multiple complications of CKD. There are many stimuli of the inflammatory response in CKD patients, such as fluid overload, decreased cytokine clearance, presence of uremia-modified proteins, presence of chronic infections, metabolic disturbances (including hyperglycemia), obesity. Many of these factors are related to PD. Latin America has made some progress in economic issues; however, a large portion of the population is still living in poverty, in poor sanitary conditions, and with many health-related issues, such as an increasing elderly population, low birth weights, and increasingly high energy intake in the adult population, which, in combination with changes in lifestyle, has provoked an increase in the prevalence of obesity, diabetes, and CVD. Therefore, in Latin America, there seems to be a peculiar situation combining high prevalence of low education level, poor sanitary conditions, and poverty with increases in obesity, diabetes, and sedentary lifestyle. Since inflammation and mortality risk are intimately related to both sides of those health issues, in this review we aim to analyze the peculiarities of inflammation and mortality risk in the Latin-American PD population.
authors.affiliation: Unidad de Investigación Médica en Enfermedades Renales, UMAE Hospital de Especialidades, CMNO, IMSS, Guadalajara, Mexico. a_cueto_manzano@hotmail.com
authors.forename: Alfonso M
authors.initials: AM
authors.lastname: Cueto-Manzano
authors.forename: Liliana
authors.initials: L
authors.lastname: González-Espinoza
authors.forename: Fabiola
authors.initials: F
authors.lastname: Martin del Campo
authors.forename: Paulo C
authors.initials: PC
authors.lastname: Fortes
authors.forename: Roberto
authors.initials: R
authors.lastname: Pecoits-Filho
mesh_terms: D015314:Dialysis Solutions; D006801:Humans; D007249:Inflammation / Q000150:complications*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D007843:Latin America; D010530:Peritoneal Dialysis / Q000009:adverse effects*
chemical_list: D015314:Dialysis Solutions